Brief: Xoma Enters Into Agreement To Acquire Kinnate Biopharma
16/02/2024 14:27
Feb 16 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* XOMA ENTERS INTO AGREEMENT TO ACQUIRE KINNATE
BIOPHARMA FOR
BETWEEN $2.3352 AND $2.5879 IN CASH PER SHARE PLUS A CONTINGENT
VALUE RIGHT
* KINNATE'S BOARD UNANIMOUSLY APPROVED MERGER AGREEMENT
* IMMEDIATELY FOLLOWING CLOSING OF TENDER OFFER, KINNATE
WILL
MERGE WITH A SUBSIDIARY OF XOMA
Source text for Eikon: ID:nGNX7Ytzqq
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview